Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 500-036-1 | CAS number: 25214-70-4
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Carcinogenicity
Administrative data
Description of key information
in summary, MDA was carcinogenic in rats and mice after oral long-term administration.
Key value for chemical safety assessment
Carcinogenicity: via oral route
Endpoint conclusion
- Dose descriptor:
- LOAEL
- 9 mg/kg bw/day
Justification for classification or non-classification
In regulation 1272/2008/EC, MDA is officially classified as carcinogen 1B, H350: may cause cancer.
According directive 67/548/EC, MDA is classified as carcinogen category 2: R45: may cause cancer.
Additional information
Justification on read-across of data for the 4,4´-isomer of MDA for oligomeric MDA in the scope of REACH is documented in IUCLID Toxicological information and described in sections 5.1 and 5.11 of the CSR.
Discussion
The most relevant assessment of carcinogenicity in animals comes from a 2-year study with 4,4'-methylenedianiline dihydrochloride
(MDA) in F344 rats and B6C3F1 mice (NTP, 1983; Weisburger et al., 1984; Lamb et al., 1986).In this study both species were administered via the drinking water with 0, 150 and 300 ppm MDA over a period of 103 weeks. The calculated average intake of MDA in low and high dose was 9 and 16 mg/kg bw/day for male rats, 10 and 19 mg/kg bw/day for female rats, 25 and 58 mg/kg bw/day for male mice as well as 19 and 43 mg/kg bw/day for female mice. Under the conditions of this study MDA was clearly carcinogenic for both species producing thyroid and liver tumors.
In rats, significantly increased incidences of thyroid follicular cell carcinomas in males, thyroid follicular cell adenomas in females, C-cell adenomas of the thyroid gland in females as well as neoplastic nodules in the liver of males were observed. Cystic and hyperplastic follicular thyroid lesions were increased in high dose females. Rats of each dose group showed toxic liver effects (fatty metamorphosis, focal cellular change). An increased incidence of renal mineralization was evident in high dose males. Survival was comparable among all groups. High dose female rats had lower mean body weights than those of the controls. No compound-related clinical signs were observed.
In mice, significantly increased incidences of thyroid follicular cell adenomas and hepatocellular carcinomas in males and females, adenomas of the liver and malignant lymphomas in females as well as adrenal pheochromocytomas in males were seen. Hyperplastic follicular thyroid lesions were increased in high dose mice of both sexes. Liver cell degeneration was observed with high incidences in males at 150 and 300 ppm and to a lesser extent in high dose females. An increased incidence of kidney nephropathy was evident in all dose groups and renal papillary mineralization was greater in males and females at 300 ppm compared to controls. Survival was reduced in high dose males. High dose groups showed reduced mean body weights from week 16 onwards. No compound-related clinical signs were observed.
Carcinogenicity: via oral route (target organ): digestive:
liver; glandular: thyroids
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.